Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / AIGH Capital Management LLC
Form 13F · Q2 2026

AIGH Capital Management LLC

CIK 1835943Filed 2026-08-0713F-HR View the filing on EDGAR ↗
$1.6B
Reported book value
89
Positions
12
Quarters on record
Top 50
Positions

AIGH Capital Management LLC — holdings

Top 42 positions of 89, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SNDK Sandisk Corp149,000−25.5%$339M21.4%
2MXL Maxlinear Inc818,000—$105M6.6%
3INTC Intel Corp623,500—$87M5.5%
4APPS Digital Turbine Inc6.5M+33.8%$84M5.3%
5SIMO Silicon Motion Technology Co144,000−28.0%$48M3.0%
6CLFD Clearfield Inc1.0M—$40M2.5%
7METHODE ELECTRS INC Methode Electrs Inc1.7M—$32M2.0%
8ASYS Amtech Sys Inc1.3M—$29M1.8%
9FENC Fennec Pharmaceuticals Inc2.5M+25.5%$27M1.7%
10KYTX Kyverna Therapeutics Inc2.8M+39.8%$25M1.6%
11NYXH Nyxoah S A14.5M—$25M1.5%
12PSNL Personalis Inc1.7M−40.9%$23M1.4%
13SOPH Sophia Genetics Sa4.0M—$23M1.4%
14DDD 3D Sys Corp Del7.3M—$22M1.4%
15VUZI Vuzix Corp6.7M+104.7%$20M1.2%
16ABEO Abeona Therapeutics Inc3.0M−3.6%$18M1.2%
17ARDX Ardelyx Inc3.2M—$16M1.0%
18BDSX Biodesix Inc678,328−10.5%$15M1.0%
19SPRB Spruce Biosciences Inc250,000—$14M0.9%
20CSTL Castle Biosciences Inc545,101−7.7%$13M0.8%
21VNDA Vanda Pharmaceuticals Inc2.0M−25.7%$13M0.8%
22PTHS Pelthos Therapeutics Inc329,098—$9M0.6%
23PYPD Polypid Ltd1.5M−5.6%$8M0.5%
24VSTM Verastem Inc1.9M−3.6%$7M0.5%
25BWEN Broadwind Inc1.2M—$6M0.4%
26LIDR Aeye Inc3.9M—$6M0.3%
27KIDS Orthopediatrics Corp269,765—$5M0.3%
28APYX Apyx Medical Corporation1.1M+2.1%$5M0.3%
29IDEAL PWR INC Ideal Pwr Inc894,731−24.3%$5M0.3%
30TLPH Talphera Inc4.6M−1.3%$5M0.3%
31TYGO Tigo Energy Inc2.0M−72.7%$5M0.3%
32WATT Energous Corp182,000−15.3%$4M0.3%
33RNXT Renovorx Inc4.4M+18.9%$4M0.3%
34RICHARDSON ELECTRS LTD Richardson Electrs Ltd200,434—$4M0.2%
35NRXS Neuraxis Inc519,938+30.0%$4M0.2%
36COYA Coya Therapeutics Inc631,912−35.2%$4M0.2%
37IDENTIV INC Identiv Inc1.4M+254.1%$4M0.2%
38ELUT Elutia Inc2.7M−25.0%$3M0.2%
39APRE Aprea Therapeutics Inc1.0M+0.0%$814,7680.1%
40BFRI Biofrontera Inc739,910−19.2%$699,5850.0%
41QNRX Quoin Pharmaceuticals Ltd70,000+37.3%$338,8000.0%
42NNBR Nn Inc11,496—$41,2710.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.